Perioperative continuous intravenous infusion of Lido and Dex significantly reduced the production of NETs (MPO and H3Cit) and the expression of tumor metastasis biomarkers (VEGF-α, MMP-3, and MMP-9) in the peripheral blood of NSCLC patients. This evidence concerns the gene VEGFA and neoplasm.